A
Antonio Craxì
Researcher at University of Palermo
Publications - 699
Citations - 44773
Antonio Craxì is an academic researcher from University of Palermo. The author has contributed to research in topics: Hepatitis C & Cirrhosis. The author has an hindex of 86, co-authored 659 publications receiving 39463 citations. Previous affiliations of Antonio Craxì include University of Pavia & University of Paris-Sud.
Papers
More filters
Journal ArticleDOI
Failure on voxilaprevir, velpatasvir, sofosbuvir and efficacy of rescue therapy
Julia Dietz,Velia Chiara Di Maio,Adolfo de Salazar,Dolores Merino,Johannes Vermehren,Stefania Paolucci,Andreas E. Kremer,Magdalena Lara,Maria Josefa Rodriguez Pardo,Heinz Zoller,Elisabetta Degasperi,Kai-Henrik Peiffer,Laura Sighinolfi,Francisco Téllez,Christiana Graf,Valeria Ghisetti,Jonas Schreiber,Elisa Fernández-Fuertes,Lucio Boglione,Leopoldo Muñoz-Medina,Rudolf E. Stauber,William Gennari,Blanca Figueruela,Jesús Santos,Pietro Lampertico,Stefan Zeuzem,Francesca Ceccherini-Silberstein,Federico García,Christoph Sarrazin,Alessio Aghemo,Tiziano Allice,Massimo Andreoni,Mario Angelico,Fausto Baldanti,Silvia Barbaliscia,Ada Bertoli,Vanni Borghi,Vincenza Calvaruso,Giuseppe Cariti,Antonio Craxì,Simona Francioso,Carlo Federico Perno,Pietro Pozzoni,Pier Luigi Toniutto,Maurizio Zazzi,Ana Belén Pérez,Cristina Quilez,Juan Carlos Alados,Joaquín Cabezas,Juan Ignacio Arenas Ruiz-Tapiador,Miguel Jimenez,Juan Manuel Pascasio-Acevedo,Manuel Alberto Macias Rodriguez,Jose Miguel Rosales Zabal,Miguel García Deltoro,Ana María Martinez Sapiña,Ana Fuentes,Natalia Chueca,Christoph P. Berg,Andreas Herrmann,Andreas Stallmach,Kerstin Port,M. Katja Deterding,Heiner Wedermeyer,Markus Cornberg,Michael P. Manns,Christophe Moreno,Julian Schulze zur Wiesch,Felix Piecha,Ansgar W. Lohse,Jürgen Siebler,Nikolaus Kordecki,Lorenzo Magenta,Burkhard Jäger,Hjördis Möller,Renate Heyne,Tomas Beyer,Stephan Grunwald,Axels Baumgarten,Eva Jägel-Guedes,Wolfgang Schmidt +80 more
TL;DR: VOX/VEL/SOF failure was mainly observed in HCV GT3 and GT1a infected patients with cirrhosis and was not associated with specific RASs pattern within NS3, NS5A or NS5B target regions.
Journal ArticleDOI
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer
TL;DR: Direct acting antivirals stabilize or improve liver function in the majority of patients with hepatitis C virus cirrhosis and could improve the prognosis of subjects, independently from the subsequent course of hepatocellular carcinoma, if the efficacy in obtaining viral clearance is as high as in patients without a history of liver cancer.
Journal Article
The detection of hbv-dna by molecular hybridization - a more sensitive method for detection of hbv particles in serum
Journal ArticleDOI
Primary Biliary Cholangitis: advances in management and treatment of the disease
Pietro Invernizzi,Annarosa Floreani,Marco Carbone,Marco Marzioni,Antonio Craxì,Luigi Muratori,Umberto Vespasiani Gentilucci,Ivan Gardini,Antonio Gasbarrini,Paola Kruger,Francesco Saverio Mennini,Virginia Ronco,EP Lanati,Pier Luigi Canonico,Domenico Alvaro +14 more
TL;DR: The present paper illustrates the opinion of a working group, composed of clinical pharmacologists, gastroenterologists/hepatologists with specific expertise on Primary Biliary Cholangitis and patient associations, on the state of the art and future perspectives of the disease management.
Journal ArticleDOI
A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C.
Vito Di Marco,Oreste Lo Iacono,Calogero Cammà,Piero Luigi Almasio,Alessandra Vaccaro,Patrizia Fuschi,Marco Giunta,Carmelo Fabiano,Luigi Pagliaro,Antonio Craxì +9 more
TL;DR: In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low, and the effect of high‐dose maintenance therapy in preventing relapse is evaluated.